PT Alkindo Naratama Tbk (IDX:ALDO)

Verve Therapeutics Balance Sheet

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	47,508	118,927	115,841	40,360	96,170	25,096
Trading Asset Securities	-	12,972	12,373	15,102	-	-
Cash & Short-Term Investments	60,536	131,899	128,214	55,462	96,170	25,096
Cash Growth	-16.34%	2.87%	131.17%	-42.33%	283.21%	33.21%
Accounts Receivable	412,490	368,385	336,870	250,341	319,322	288,885
Other Receivables	19,060	16,387	30,954	23,284	5,532	5,750
Receivables	431,550	384,772	367,824	273,625	324,854	294,635
Inventory	443,420	418,382	371,397	362,228	258,888	207,219
Prepaid Expenses	22,652	4,040	3,241	2,336	2,194	2,970
Other Current Assets	-	8,012	6,141	20,459	28,128	6,607
Total Current Assets	958,158	947,105	876,816	714,111	710,234	536,526
Property, Plant & Equipment	1,045,193	1,060,363	852,287	849,986	495,848	411,440
Long-Term Deferred Tax Assets	36,827	34,400	17,925	2,799	2,638	3,961
Long-Term Deferred Charges	-	303.96	131.04	-	13.46	32.66
Other Long-Term Assets	4,851	4,510	4,544	1,911	2,076	1,592
Total Assets	2,045,028	2,046,681	1,751,703	1,568,807	1,210,809	953,552
Accounts Payable	306,316	380,154	306,861	211,344	241,048	188,421
Accrued Expenses	18,021	10,933	10,505	8,148	7,900	11,231
Short-Term Debt	377,649	289,016	292,091	217,865	107,242	27,987
Current Portion of Long-Term Debt	68,165	58,332	39,698	21,376	16,329	57,898
Current Portion of Leases	7,702	6,089	5,259	3,405	4,128	4,039
Current Income Taxes Payable	-	4,366	4,969	5,392	10,702	6,977
Other Current Liabilities	19,673	18,322	20,624	40,478	593.7	7,334
Total Current Liabilities	797,527	767,213	680,008	508,008	387,942	303,887
Long-Term Debt	185,341	222,569	230,901	274,781	97,336	31,958
Long-Term Leases	5,614	4,960	6,760	2,242	3,418	3,277
Long-Term Deferred Tax Liabilities	52.67	71.91	-	224.96	102.9	-
Total Liabilities	1,013,795	1,019,907	941,765	803,638	507,407	363,428
Common Stock	135,036	135,036	135,036	131,686	131,686	110,000
Additional Paid-In Capital	326,039	327,130	327,130	285,637	288,055	144,983
Retained Earnings	335,108	329,433	339,165	341,389	277,301	208,111
Treasury Stock	-122.85	-	-	-1,945	-1,572	-913.37
Comprehensive Income & Other	227,984	227,984	2,193	2,193	2,193	-3,030
Total Common Equity	1,024,043	1,019,582	803,523	758,960	697,662	459,151
Minority Interest	7,190	7,192	6,414	6,209	5,740	130,973
Shareholders' Equity	1,031,233	1,026,774	809,938	765,169	703,403	590,124
Total Liabilities & Equity	2,045,028	2,046,681	1,751,703	1,568,807	1,210,809	953,552
Total Debt	644,471	580,966	574,710	519,669	228,453	125,159
Net Cash (Debt)	-583,934	-449,068	-446,496	-464,207	-132,283	-100,064
Net Cash Per Share	-216.35	-166.28	-168.31	-176.26	-60.06	-45.48
Filing Date Shares Outstanding	2,701	2,701	2,701	2,595	2,602	2,182
Total Common Shares Outstanding	2,701	2,701	2,701	2,595	2,602	2,182
Working Capital	160,631	179,893	196,808	206,103	322,291	232,639
Book Value Per Share	379.18	377.52	297.52	292.49	268.10	210.45
Tangible Book Value	1,024,043	1,019,582	803,523	758,960	697,662	459,151
Tangible Book Value Per Share	379.18	377.52	297.52	292.49	268.10	210.45
Land	-	307,881	78,196	76,316	76,316	71,462
Buildings	-	358,967	348,231	197,121	191,947	173,802
Machinery	-	775,574	743,872	390,341	370,969	346,527
Construction In Progress	-	8,702	8,947	453,291	93,300	27,821

Source: S&P Global Market Intelligence. Standard template. Financial Sources.